Has published the following technical notes on 28th August
Submitted by sixth form student Portia Smith
Apparently, I’m the youngest person ever to present at a BNMS conference. I’m in my first year of sixth form college, and have just presented a poster at the Spring Meeting, 2017. Thanks to the nuclear medicine department at the Royal Sussex County Hospital, led by Dr Sabina Dizdarevic, I had the opportunity to raise awareness for Tc-99m-MIBI accumulation in axillary apocrine sweat glands. In this region, high sudation levels can mimic lymphadenopathy in patients with parathyroid adenoma and malignancy, potentially prompting unnecessary intervention or surgery.
Dr Sabina Dizdarevic and Portia Smith and her poster 'Don't forget sweat gland MIBI accumulation' at BNMS2017.
latest from ONR Transport
On the non-nuclear transport front, inspections, stakeholder engagement and policy work in support of BEIS as BSSD implementation draws closer have all been matters occupying the Transport Inspection and Enforcement Team recently. Here are the headlines from the last few months.
We would like to congratulate Dr John Buscombe for being elected as President-Elect of the BNMS following the Annual General Meeting held at 17.00 on Sunday 21st May at ICC, Birmingham.
John will be President-Elect for one year, followed by two years as President and another year as Immediate Past-President, for a total term of four years.
In this respect, we would like to say a big thank you to Dr Alp Notghi, who has now finished his term as Immediate Past President.
The 45th Annual Spring Meeting of the British Nuclear Medicine Society (BNMS) took place on 20th - 22nd May 2017. The event was hosted at the International Convention Centre (ICC), Birmingham, for the 2nd year in a row with over 450 delegates attending over the 3 days.
The meeting provided a knowledge update for all those involved in Nuclear Medicine including clinicians, clinical scientists, radiopharmacists, radiographers, technologists and nurses, with a specific focus on UK practice. The large and impressive exhibition hall at the ICC provided a good environment for networking and interfacing with colleagues from industry with 28 exhibitors in attendance this year. There were over 60 invited speakers, with Professor Irene Virgolini, of the Medical University of Innsbruck, Austria, delivering this year’s annual lecture on ‘Radionuclide Theranostics in Prostate Cancer’.
The next scheduled BNMS meeting is the Autumn Meeting on 15th September 2017, in Liverpool.
By Manil Subesinghe
Blue Earth Diagnostics has received EU marketing authorisation for Axumin (fluciclovine (18F)) for PET imaging of recurrent prostate cancer.